ARTLVSMRNA• 3 Months (Normalized)
ARTL vs MRNA (Artelo Biosciences Inc. vs Moderna Inc.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-54.55%
Artelo Biosciences Inc.
Normalized Baseline0.00%
MRNA Performance $182.11
+%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-54.55 pts
MRNA outperforming by 54.55 percentage points
ARTLMRNA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(60 dates)
| Date | ARTL Price | ARTL Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -54.55% | $- | - | |
| Sep 24, 2026 | $5.17 | -48.25% | $- | - | |
| Sep 23, 2026 | $7.31 | -26.83% | $182.11 | +128.32% | -155.15% |
| Sep 22, 2026 | $4.15 | -58.46% | $182.56 | +128.89% | -187.35% |
| Sep 21, 2026 | $4.10 | -58.96% | $172.94 | +116.83% | -175.79% |
| Sep 18, 2026 | $3.94 | -60.56% | $154.04 | +93.13% | -153.69% |
| Sep 17, 2026 | $3.97 | -60.26% | $158.07 | +98.18% | -158.44% |
| Sep 16, 2026 | $3.75 | -62.46% | $145.62 | +82.57% | -145.03% |
| Sep 15, 2026 | $5.34 | -46.55% | $143.77 | +80.25% | -126.80% |
| Sep 14, 2026 | $4.87 | -51.25% | $146.69 | +83.91% | -135.16% |
| Sep 11, 2026 | $5.43 | -45.65% | $143.97 | +80.50% | -126.15% |
| Sep 10, 2026 | $5.63 | -43.64% | $136.62 | +71.29% | -114.93% |
| Sep 09, 2026 | $5.98 | -40.14% | $135.61 | +70.02% | -110.16% |
| Sep 08, 2026 | $6.19 | -38.04% | $140.33 | +75.94% | -113.98% |
| Sep 04, 2026 | $6.04 | -39.54% | $145.55 | +82.48% | -122.02% |
Page 1 of 4